VIP (etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma

We retrospectively reviewed outcomes of treatment with VIP (combination of etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma (STS). We analyzed the medical records of patients with advanced or relapsed STS who had undergone VIP treatment as second-line or...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Medicine (Baltimore)
Autori principali: Moon, Ji Young, Baek, Seung-Woo, Ryu, Hyewon, Choi, Yoon-Seok, Song, Ik-Chan, Yun, Hwan-Jung, Jo, Deog-Yeon, Kim, Samyong, Lee, Hyo Jin
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2017
Soggetti:
5700
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5287961/
https://ncbi.nlm.nih.gov/pubmed/28121937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000005942
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi